Android Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.56 Cr
as on 17-07-2024
- Satisfied Charges ₹ 2.50 M
as on 17-07-2024
- Revenue 23.77%
(FY 2022)
- Profit -195.74%
(FY 2022)
- Ebitda -30.24%
(FY 2022)
- Net Worth -3.76%
(FY 2022)
- Total Assets 6.79%
(FY 2022)
About Android Bioscience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.56 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Vaghasia and Divyesh Sakariya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC070654
- Company No.
070654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Android Bioscience Private Limited offer?
Android Bioscience Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Ayurvedic Digestive Medicine, Digestive Enzyme Syrup, Anti Infective Agent, Ofloxacin Oral Suspension, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Allopathic Cough Syrup, Ambroxol Hydrochloride Syrup.
Who are the key members and board of directors at Android Bioscience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divyesh Sakariya  | Director | 21-Nov-2016 | Current |
| Gopal Vaghasia | Director | 21-Nov-2016 | Current |
Financial Performance of Android Bioscience.
Android Bioscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.77% increase. The company also saw a substantial fall in profitability, with a 195.74% decrease in profit. The company's net worth dipped by a decrease of 3.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Android Bioscience?
In 2022, Android Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adnova Healthcare Private LimitedActive 9 years 4 monthsGopal Vaghasia and Divyesh Sakariya are mutual person
Revo Medicare Private LimitedActive 12 years 5 monthsGopal Vaghasia and Divyesh Sakariya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 07 Jun 2021 | ₹1.61 Cr | Open |
Sidbi Creation Date: 06 Jul 2020 | ₹5.00 M | Open |
Sidbi Creation Date: 27 Dec 2016 | ₹4.45 Cr | Open |
How Many Employees Work at Android Bioscience?
Unlock and access historical data on people associated with Android Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Android Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Android Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
